To be sure, if you're testing the new platform for a medical technology and can't scrounge up 350 people for your study, there's no faith that you're going to make something that actually works.
It would be far wiser to build a treatment for something where you can get a significant sample size to prove out the platform, and then move into smaller populations from there, building on the newly gained knowledge.
Data speaks, and statistics are how we listen. If you can't do the stats, you shouldn't try to claim an advance.
It would be far wiser to build a treatment for something where you can get a significant sample size to prove out the platform, and then move into smaller populations from there, building on the newly gained knowledge.
Data speaks, and statistics are how we listen. If you can't do the stats, you shouldn't try to claim an advance.